Significant Ownership of Leonite Fund I, LP

Signature - Title
Avi Geller - Chief Investment Officer
Location
Spring Valley, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Leonite Fund I, LP.

Notify me when Leonite Fund I, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Leonite Fund I, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RSLS ReShape Lifesciences Inc. Common Shares, $0.001 par value per share 6.1% $76,000 200,000 Leonite Fund I, LP 18 Feb 2025
HSDT HELIUS MEDICAL TECHNOLOGIES, INC. Common Shares, $0.001 par value per share 5.2% $699,506 163,055 Leonite Fund I, LP 05 Jun 2025

Schedules 13D/G Reported by Leonite Fund I, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.